Gao L, et al. – Study authors sought to validate the expression of miR–133a–3p in bladder cancer (BC) and provide insights into the molecular mechanism underlying it. Possessing great diagnostic potential with its downregulation in BC, miR–133a–3p appeared as a novel biomarker for BC.